MARKSANSWeekly Breakout Done.
Accumulation Done.
Huge Volumes.
Good for Short Term.
Do Like ,Comment , Follow for regular Updates...
Keep Learning ,Keep Earning...
Disclaimer : This is not a Buy or Sell recommendation. I am not SEBI Registered. Please consult your financial advisor before making any investments . This is for Educational purpose only.
MARKSANS
Marksans Pharma Ltd - Breakout Setup, Move is ON...#MARKSANS trading above Resistance of 180
Next Resistance is at 212
Support is at 134
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
#JUBLPHARMA 435 TGT 590 SL 400 Buy Recommended - Rachit SethiaJUBLPHARMA 435
Target 590
SL 400
Return 43%
RR > 4.5
TF < 6 Months
Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming. If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations. With 💚 from Rachit Sethia
#IPCALAB #MOREPENLAB #DRREDDY #LAURUSLABS #DIVISLABS #AUROPHARMA#IPCALAB
NSE: IPCALAB
CMP: 864
TP: 980
SL: 840
TF: <6m
RR > ~4.5 times
Return > 13%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#GLENMARK #SANOFI #PFIZER #BPLPHARMA #MARKSANS #BIOCON #GRANULES#GLENMARK
NSE: GLENMARK
CMP: 440
TP: 515
SL: 400
TF: <6m
RR > 2 times
Return > 17%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
MARKSANS PHARMA LTD Trend AnalysisAn undervalued debt free small cap pharma with strong fundamentals available at a PE below 8.
A potential Cup with Handle pattern is forming.
Expecting price to reach green support zone highlighted, Golden FIB and Pitchfork edge is adding more confluence to that level.
Good to accumulate around 35-40 levels for the following targets:
Short term swing target @ 67 (78.5% ROI with 3.93 R:R)
Medium term positional target @ 105 (180% ROI with 9 R:R)
Long term positional target @ 180 (380% ROI with 19 R:R)
Stop loss @ 30
As always, do your own due diligence before taking any action.
Peace!!
Marksans Pharma_Buy call for a target of 16% profitDate: 04 Aug 2020
Marksans Pharma (CMP: 41.60)
Ascending Triangle Pattern formation with MACD breakout and strong RSI signals.
Fundamentally its a good company with strong growth in YoY quarterly profit and sales. Virtually debt free company.
Target 48.50. Profit potential 16%.
T1-42.50, T2- 45.50, T3- 48.50; SL- 36.50